hc1 Unveils HerCare Designed to Safeguard Maternal Health
hc1 has launched HerCare, a new module in its MyBloodHealth platform, to enhance maternal health by providing real-time lab-driven insights.
hc1 has launched HerCare, a new module in its MyBloodHealth platform, to enhance maternal health by providing real-time lab-driven insights.
Researchers identified genes closely linked to both rheumatoid arthritis and osteoporosis, offering diagnostic markers for these diseases.
Endometriosis affects over 11% of women and remains challenging to diagnose early, with researchers exploring new diagnostic methods.
The test monitors pregnant women for Toxoplasma gondii infections, and detects infections within 30 minutes from a finger-prick.
Read MoreLabs should consider self-reported race when screening for open neural tube defects to improve prenatal care equity for Black individuals.
Read MoreLabcorp has introduced a first trimester preeclampsia screening test to assess preeclampsia risk between 11- and 14-weeks’ gestation.
Read MorePinkDx, an early-stage company focused on positively impacting the health of women, launched with $40 million in Series A financing.Â
Read MoreResearchers in the U.S. and the Netherlands have now used a large dataset to build more accurate cardiovascular risk models.
Read MoreClinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Read MoreAgilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read MoreThe AMH Assay can support a lab’s reproductive endocrinology test menu as it aids a physician’s assessment of initiating IVF with a patient.
Read MoreThe test is for use with the Triage MeterPro for the quantitative determination of placental growth factor in maternal plasma specimens.Â
Read MoreA new algorithm may help identify high-risk precancerous lesions on the fallopian tubes thought to lead to a common form of ovarian cancer
Read MoreCLP’s Chris Wolski interviews Sara Naseri, MD, co-founder and CEO of Qvin, about a menstrual pad that collects blood for diagnostic purposes.
Read MoreFort Worth Diagnostics utilizes digital PCR to establish the assays and ensure reproducibility while manufacturing high-quality materials.
Read MoreThe test measures angiogenic biomarkers associated with preeclampsia, serum soluble fms-like tyrosine kinase 1 and placental growth factor.
Read MoreScientists combined machine learning with info on blood metabolites to develop a new test able to detect ovarian cancer with 93% accuracy.
Read MoreNatera has acquired certain assets from Invitae relating to its non-invasive prenatal screening and carrier screening business.
Read More